chr8-58808157-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014729.3(TOX):c.1505C>A(p.Pro502Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,613,918 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P502R) has been classified as Uncertain significance.
Frequency
Consequence
NM_014729.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000877 AC: 22AN: 250840 AF XY: 0.000103 show subpopulations
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461706Hom.: 1 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 727140 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74356 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1505C>A (p.P502Q) alteration is located in exon 8 (coding exon 8) of the TOX gene. This alteration results from a C to A substitution at nucleotide position 1505, causing the proline (P) at amino acid position 502 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at